イムノセンス
5 employees on LinkedIn · 2 known investors
Find your way into イムノセンス
Sign up to see every warm intro you have to イムノセンス
- Paths you didn't know you had: your email and LinkedIn already hold routes to the イムノセンス team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IMMUNOSENS manufactures in vitro diagnostic pharmaceuticals and third-class medical devices for clinical diagnostic purposes. The company holds regulatory approvals from Japanese authorities for these medical products.
Investors · 2
Frequently asked questions
- What does イムノセンス do?
- IMMUNOSENS manufactures in vitro diagnostic pharmaceuticals and third-class medical devices for clinical diagnostic purposes. The company holds regulatory approvals from Japanese authorities for these medical products.
- Who are イムノセンス's investors?
- イムノセンス's investors include Global Brain, OSAKA University Venture Capital.

